Bo Jiao
Shanghai Jiao Tong University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Ruijin Hospital(CN)London Cancer(GB)Shanghai Children's Medical Center(CN)Zhejiang Cancer Hospital(CN)State Power Investment Corporation (China)(CN)Zhejiang University Medical College Affiliated Stomatological Hospital(CN)Stomatology Hospital(CN)Zhengzhou Central Hospital(CN)Shanghai Institute of Hematology(CN)Shanghai First Maternity and Infant Hospital(CN)Zhejiang University(CN)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Acute Lymphoblastic Leukemia research, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research
Most-Cited Works
- → WT1 Recruits TET2 to Regulate Its Target Gene Expression and Suppress Leukemia Cell Proliferation(2015)303 cited
- → Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK–YAP Signaling(2021)90 cited
- → Deuterated Clopidogrel Analogues as a New Generation of Antiplatelet Agents(2013)76 cited
- → Palmitoylacyltransferase Zdhhc9 inactivation mitigates leukemogenic potential of oncogenic Nras(2015)75 cited
- → AML1-ETO9a is correlated with C-KIT overexpression/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2(2009)70 cited
- → Newly diagnosed acute lymphoblastic leukemia in China (II): prognosis related to genetic abnormalities in a series of 1091 cases(2012)70 cited